There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
To estimate and compare recurrence rates, index of recurrence, and disease-free interval
in patients with superficial recurrent bladder cancer receiving bacille Calmette-Guérin
(BCG) or interferon (IFN) for immunoprophylaxis.